Trial intelligence / Profile preview

Cetirizine vs Ketotifen in Pediatric Perennial Allergic Rhinitis

NCT00639587Phase 3Completed

Sponsor
UCB
Start
Aug 2002
Primary completion
Mar 2003
Modality
Small Molecules
01

Overview

A Phase 3 trial of cetirizine in perennial allergic rhinitis (PAR), sponsored by UCB. Started Aug 2002; status: completed.

02

Drugs

cetirizine
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00639587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00639587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call